BK virus: A clinical review

Clinical Infectious Diseases

Volumn 33, Issue 2, 2001, Pages 191-202

  Reploeg, Mark D ^a   Storch, Gregory A ^a   Clifford, David B ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BK VIRUS; BONE MARROW TRANSPLANTATION; HEMORRHAGIC CYSTITIS; IMMUNE DEFICIENCY; JC VIRUS; NEPHRITIS; PRIORITY JOURNAL; PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY; REVIEW; VIRUS CHARACTERIZATION; VIRUS DETECTION;

ANIMALS; AUTOIMMUNE DISEASES; BK VIRUS; EYE DISEASES; HUMANS; KIDNEY DISEASES; LIVER DISEASES; LUNG DISEASES; NEOPLASMS; NERVOUS SYSTEM DISEASES; PAPILLOMAVIRUS INFECTIONS; TUMOR VIRUS INFECTIONS; VIRUS LATENCY;

EID: 0035879598     PISSN: 10584838     EISSN: None     Source Type: Journal    
DOI: 10.1086/321813     Document Type: Review

References (158)

1. New human papovavirus (B.K.) isolated from urine after renal transplantation
2. Cultivation of papovalike virus from human brain with progressive multifocal leukoencephalopathy
3. Polyomaviruses
4. Prevalence of antibodies in human sera against JC virus, an isolate from a case of progressive multifocal leukoencephalopathy
5. High prevalence of antibodies to BK virus, and SV-40 related papovavirus, in residents in Maryland
6. Prevalence in Italy of antibodies to a new human papovavirus (BK Virus)
7. Prevalence in England of antibody to human polyomavirus (B.K.)
8. A human papovavirus (B.K.), biological properties and seroepidemiology
9. BK virus infection in patients with AIDS
10. BK virus: I. Seroepidemiologic studies and serologic response to viral infection
11. The role of BK virus in acute respiratory tract disease and the presence of BKV DNA in tonsils
12. JCV-DNA and BKV-DNA in the CNS tissue and CSF of AIDS patients and normal subjects: Study of 41 cases and review of the literature
13. Detection of polyomaviral DNA sequences in normal and adenomatous human pituitary tissues using the polymerase chain reaction
14. Virologic diagnosis of progressive multifocal leukoencephalopathy: Detection of JC Virus DNA in cerebrospinal fluid and brain tissue of AIDS patients
15. Polyomavirus latency and human tumors
16. High incidence of BK virus large-T-antigen-coding sequences in normal human tissues and tumors of different histotypes
17. Detection of BK virus DNA in nasopharyngeal aspirates from children with respiratory infections but not in saliva from immunodeficient and immunocompetent adult patients
18. Latent BK virus infection and Kaposi's sarcoma pathogenesis
19. Disseminated BK type polyomavirus infection in an AIDS patient associated with central nervous system disease
20. Cloning and characterization of BK virus-related DNA sequences from normal and neoplastic human tissues
21. Infection of human polyomaviruses JC and BK in peripheral blood leukocytes from immunocompetent individuals
22. BK and JC viruses in human immunodeficiency virus type 1-infected persons: Prevalence, excretion, viremia, and viral regulatory regions
23. Duplex polymerase chain reaction for the simultaneous detection of the human polyomavirus BK and JC DNA
24. The persistence of papovavirus BK DNA sequences in normal human renal tissue
25. Distribution of nonintegrated DNA from JC papovavirus in organs of patients with progressive multifocal leukoencephalopathy
26. Persistence of DNA sequences of BK virus and JC virus in normal human tissues and in diseased tissues
27. Evidence of human polyomavirus BK and JC infection in normal brain tissue
28. Presence of human polyomavirus DNA in the peripheral circulation of bone marrow transplant patients with and without hemorrhagic cystitis
29. High frequency of polyomavirus infection in lymphoid cell preparations after allogeneic bone marrow transplantation
30. JC virus DNA is present in many human brain samples from patients without progressive multifocal leukoencephalopathy
31. PCR detection of JC virus DNA in brain tissue from patients with and without progressive multifocal leukoencephalopathy
32. Detection of polyomaviral DNA in clinical samples from immunocompromised patients: Correlation with clinical disease
33. Molecular biology and pathogenesis of human polyomavirus infections
34. Transplacental transmission of BK virus in human
35. Transplacental transmission of human polyomavirus BK
36. Association between polyomaviruria and microscopic hematuria in bone marrow transplant recipients
37. Association of BK viruria with hemorrhagic cystitis in recipients of bone marrow transplants
38. Acute hemorrhagic cystitis of childhood and papovavirus-like particles
39. Diagnosis of childhood BK virus cystitis by electron microscopy and PCR
40. BK virus and nonhemorrhagic cystitis in a child
41. A serological investigation of BK virus in JC virus infections in recipients of renal allografts
42. Human polyomavirus infection in renal allograft recipients
43. Association of BK virus with failure of prophylaxis against hemorrhagic cystitis following bone marrow transplantation
44. Primary BK virus (BKV) infection due to possible BKV transmission during bone marrow transplantation is not the major cause of hemorrhagic cystitis in transplanted children
45. Late-onset hemorrhagic cystitis following bone marrow transplantation: A case report
46. Urological treatment and clinical course of BK polyomavirus-associated hemorrhagic cystitis in children after bone marrow transplantation
47. Human polyomavirus (BK) infection and ureteric stenosis in renal allograft recipients
48. A prospective study of the human polyomaviruses BK and JC and cytomegalovirus in renal transplant recipients
49. BK virus as the cause of meningoencephalitis, retinitis, and nephritis in a patient with AIDS
50. Tubulo-interstitial nephritis due to a mutant polyomavirus BK virus strain, BKV(Cin), causing end-stage renal disease
51. Tubulo-interstitial nephritis associated with polyomavirus (BK type) infection
52. Renal failure due to BK virus infection in an immunodeficient child
53. Polyomavirus-induced interstitial nephritis in two renal transplant recipients: Case reports and review of the literature
54. BK virus infection in a kidney allograft diagnosed by needle biopsy
55. Human polyoma virus-associated interstitial nephritis in the allograft kidney
56. Polyomavirus infection of renal allograft recipients: From latent infection to manifest disease
57. Diagnosis and management of BK polyomavirus interstitial nephritis in renal transplant recipients
58. BK virus renal infection in a patients with the acquired immunodeficiency syndrome
59. BK virus infection in AIDS
60. Human polyoma virus infection of renal allografts: Histopathologic diagnosis, clinical significance, and literature review
61. BK papova virus pneumonia following hematopoietic stem cell transplantation
62. Human papovavirus isolated from urine of a child with acute tonsilitis
63. Identification of BK virus in a patient with acquired immune deficiency syndrome and bilateral atypical retinitis
64. Papovavirus excretion following marrow transplantation: Incidence and association with hepatic dysfunction
65. Characterization of BK virus variants rescued from human tumours and tumour cell lines
66. Association of polyomavirus JC, SV40, and BK with human brain tumors
67. High incidence of ependymomas induced by BK virus, a human papovavirus: Brief communication
68. Association of BK virus with human brain tumors and tumors of pancreatic islets
69. Isolation of papovavirus from brain tumor and urine of a patient with Wiskott-Aldrich Syndrome
70. A possible contributory role of BK virus infection in neuroblastoma development
71. Lack of association of human polyomaviruses with human brain tumors
72. BK virus in brain tumors
73. Analysis of human tumors and human malignant cell lines for BK virus-specific DNA sequences
74. Occurrence of BK virus DNA in DNA obtained from certain human tumors
75. Evaluation of normal and neoplastic human tissue for BK virus
76. Screening human tumor samples with a broad-spectrum polymerase chain reaction method for the detection of polyomaviruses
77. Lack of association between BK virus and ependymomas, malignant tumors of pancreatic islets, osteosarcomas and other human tumors
78. Morphological, histochemical, immunohistochemical, and ultrastructural characterization of tumors and dysplastic and non-neoplastic lesions arising in BK virus/tat transgenic mice
79. Upregulation of urokinase-type plasminogen activator by endogenous and exogenous HIV-1 tat protein in tumour cell lines derived from BK Virus/tat-transgenic mice
80. Promotion of tumour metastasis and induction of angiogenesis by native HIV-1 Tat protein from BK virus/tat transgenic mice
81. HIV type 1 extracellular Tat protein stimulates growth and protects cells of BK virus/tat transgenic mice from apoptosis
82. BK virus as a potential cofactor in human cancer
83. Large T antigens of many polyomaviruses are able to form complexes with the retinoblastoma protein
84. Novel mechanisms if E2F induction by BK virus large-T antigen: Requirement of both the pRb-binding and the J domains
85. Chromosomal aberrations induced by BK virus T antigen in human fibroblasts
86. High titers of antibodies to two human polyomaviruses, JCV and BKV, correlate with increased frequency of chromosomal damage in human lymphocytes
87. DNA rearrangements impairing BK virus productive infection in urinary tract tumors
88. A steroid hormone response unit in the late leader of the noncoding control region of the human polyomavirus BK confers enhanced host cell permissivity
89. Concerted expression of BK virus large T- and small T-antigens strongly enhances oestrogen receptor-mediated transcription
90. BK and JC viruses in patients with systemic lupus erythematosus: Prevalent and persistent BK viruria, sequence stability of the viral regulatory regions, and nondetectable viremia
91. BK virus encephalitis in an immunocompetent patient
92. Rise in antibodies to human papova virus BK and clinical disease
93. Episomal DNA of a BK virus variant in a human insulinoma
94. Epidemiologic clues to the etiology of Kaposi's sarcoma
95. A prospective study of human polyomavirus infection in pregnancy
96. BK virus: II. Serologic studies in children with congenital disease and patients with malignant tumors and immunodeficiencies
97. Papova virus in urine after renal transplantation
98. Incidence of BK virus and JC virus viruria in human immunodeficiency virus-infected and -uninfected subjects
99. Detection of JC and BK viral genome in specimens of HIV-1 infected subjects
100. Late-onset hemorrhagic cystitis associated with urinary excretion of polyomaviruses after bone marrow transplantation
101. BK virus infection of the human urinary tract
102. Polyomavirus persistence in lymphocytes: Prevalence in lymphocytes from blood donors and healthy personnel of a blood transfusion centre
103. Genotypes of human polyomaviruses in urine samples of pregnant women in Taiwan
104. Evidence for reactivation of persistent infection during pregnancy and lack of congenital transmission of BK virus, a human papovavirus
105. Activation of human polyomavirus infection-detection by cytologic techics
106. High incidence of urinary JC virus excretion in nonimmunosuppressed older patients
107. Human polyomavirus infections with JC virus and BK virus in renal transplant patients
108. Polyomavirus disease under new immunosuppressive drugs: A cause of renal graft dysfunction and graft loss
109. Testing for polyomavirus type BK DNA in plasma to identify renal-allograft recipients with viral nephropathy
110. Antibodies to dsDNA are produced during primary BK virus infection in man, indicating that anti-dsDNA antibodies may be related to virus replication in vivo
111. Polyoma induced autoimmunity to DNA; experimental systems and clinical observations in human SLE
112. Human polyomavirus BK and immunogenicity of mammalian DNA: A conceptual framework
113. In vivo expression of a single viral DNA-binding protein generates systemic lupus erythematosus-related autoimmunity to double-stranded DNA and histones
114. Inoculation with BK virus may break immunological tolerance to histone and DNA antigens
115. Experimental expression in mice and spontaneous expression on human SLE of polyomavirus T-antigen
116. Different genotypes of human polyomaviruses found in patients with autoimmune diseases in Taiwan
117. Mutagenic activity of BKV and JCV in human and other mammalian cells
118. Transformation of human embryonic fibroblasts by BK virus, BK virus DNA and a subgenomic BK virus DNA fragment
119. BK virus-induced osteosarcoma (Os515) as a model of human osteosarcoma
120. Induction of malignant subcutaneous sarcomas in hamsters by a recombinant DNA containing BK virus early region and the activated human c-Harvey-ras oncogene
121. Persistent BK papovavirus infection of transformed human fetal brain cells
122. The enigmas of Kaposi's sarcoma
123. The role of HHV-8 in Kaposi's sarcoma
124. The Human Polyomaviruses, BKV and JCV: Molecular pathogenesis of acute disease and potential role in cancer
125. Evolutionary changes of transcriptional control region in a minute-plaque viable deletion mutant of BK virus
126. At least two types of control regions can be found among naturally occurring BK virus strains
127. Structure and function of the transcriptional control region of nonpassaged BK virus
128. Prevalence of the archetypal regulatory region and sequence polymorphisms in nonpassaged BK virus variants
129. Antigenic and transforming properties of the DB strain of the human polyomavirus BK virus
130. Molecular and biological properties of BK virus-IR, a BK virus variant isolated from a human tumor
131. Noncoding control region of naturally occurring BK virus variants: Sequence comparison and functional analysis
132. The genome of human papovavirus BKV
133. Amplification and rearrangement in hepatoma cell DNA associated with integrated hepatitis B virus DNA
134. Structure of the transforming region of human cytomegalovirus AD 169
135. Growth efficiency of naturally occurring BK virus variants in vivo and in vitro
136. Genomic typing of BK virus in clinical specimens by direct sequencing of polymerase chain reaction products
137. Prevalence and distribution of BK virus subtypes in healthy people and immunocompromised patients detected by PCR-restriction enzyme analysis
138. Trans-activation of the human immunodeficiency virus long terminal repeat sequence by DNA viruses
139. Trans-activation of the JC virus late promoter by the tat protein of type 1 human immunodeficiency virus in glial cells
140. Pathogenesis and molecular biology of progressive multifocal leukoencephalopathy, the JC virus-induced demyelinating disease of the human brain
141. Progressive multifocal leukoencephalopathy
142. Dual qualitative-quantitative nested PCR for detection of JC virus in cerebrospinal fluid: High potential for evaluation and monitoring of progressive multifocal leukoencephalopathy in AIDS patients receiving highly active antiretroviral therapy
143. JC virus DNA load in patients with and without progressive multifocal leukoencephalopathy
144. Polymerase chain reaction for detection of JC virus DNA in cerebrospinal fluid: A quality control study
145. Detection of JC virus DNA by polymerase chain reaction in patients with progressive multifocal leukoencephalopathy
146. Amplification of JC virus DNA from brain and cerebrospinal fluid of patients with progressive multifocal leukoencephalopathy
147. Progressive multifocal leukoencephalopathy: Diagnosis by in situ hybridization with a bio-tinylated JC virus DNA probe using an automated histomatic codeon slide stainer
148. Detection of JC virus in cerebrospinal fluid (CSF) samples from patients with progressive multifocal leukoencephalopathy but not CSF samples from patients with herpes simplex encephalitis, enteroviral meningitis, or multiple sclerosis
149. Analysis of PCR as a tool for detection of JC virus DNA in cerebrospinal fluid for diagnosis of progressive multifocal leukoencephalopathy
150. Papovavirus detection by electron microscopy in the brain of an elderly patient without overt progressive multifocal leukoencephalopathy
151. PCR detection of JC virus DNA in the brain tissue of a 9-year-old child with pleomorphic xanthoastrocytoma
152. JC virus detection by in situ hybridization in brain tissue from elderly patients
153. JCV-DNA in CNS of AIDS patients with and without PML
154. Detection of JC virus by anti-VP1 immunohistochemistry in brains with progressive multifocal leukoencephalopathy
155. JC virus infection and Alzheimer's disease: Reappraisal of an in situ hybridization approach
156. Aplastic anaemia, bone-marrow transplantation, and polyoma and other virus infections
157. Management of chickenpox in the adult: A review prepared for the UK Advisory Group on chickenpox on behalf of the British Society for the study of infection